首页> 外文学位 >Development of a polymeric nanoparticulate delivery system for indocyanine green.
【24h】

Development of a polymeric nanoparticulate delivery system for indocyanine green.

机译:开发用于吲哚菁绿的聚合物纳米颗粒输送系统。

获取原文
获取原文并翻译 | 示例

摘要

Purpose. The objective of this project was to develop an intravenously administrable poly(dl-lactic-co-glycolic acid) (PLGA) nanoparticulate delivery system for Indocyanine Green (ICG), to enhance the potential for ICG use in tumor imaging and therapy.; Methods. For this purpose PLGA nanoparticles entrapping ICG were engineered by spontaneous emulsification solvent diffusion method. ICG entrapment in nanoparticles was determined and physicochemical characterization of nanoparticles was performed. The stability of ICG in nanoparticles formulation under various conditions was determined. The intracellular uptake of ICG in nanoparticles by B16-F10 and C-33A cancer cell lines was studied in comparison with the free ICG solution. Anti-proliferation studies against cancer cells were performed to prove the photodynamic activity of ICG in nanoparticles. Biodistribution of ICG when delivered through nanoparticles and solution were evaluated in mice after tail vein injection.; Results. PLGA nanoparticles with a mean diameter of 350 nm and 74% ICG entrapment were obtained. The nanoparticles were nearly spherical in shape with zeta potential of -16 mV. The nanoparticles formulation provided overall stability to ICG with degradation half-lives of 2.5--3.5 days as compared to 10--20 hr of free ICG solutions. The intracellular uptake of ICG through nanoparticles was directly proportional to time and extracellular nanoparticle concentration. The intracellular uptake of ICG was enhanced about 100-fold by nanoparticles formulation as compared to the free ICG solution. Nanoparticles formulation showed significant photodynamic effect at nano-molar ICG concentrations and very low light dose (fluence: 0.22 W/cm2 and energy density: 1.1 J/cm2). In-vivo, the blood circulation-time and retention-time of ICG in various organs was enhanced 2--5 times by nanoparticles formulation as compared to the free ICG solution.; Conclusions. A PLGA nanoparticlute delivery system was developed for ICG, which demonstrated its capability in enhancing the potential of ICG use in tumor diagnosis and anticancer therapy.
机译:目的。该项目的目的是开发一种用于吲哚菁绿(ICG)的静脉内给药聚(dl-乳酸-乙醇酸)(PLGA)纳米微粒递送系统,以增强ICG在肿瘤成像和治疗中的潜力。方法。为此目的,通过自发乳化溶剂扩散法对包埋ICG的PLGA纳米颗粒进行了工程设计。确定了纳米颗粒的ICG截留并进行了纳米颗粒的理化表征。测定了在各种条件下纳米颗粒制剂中ICG的稳定性。与游离ICG溶液相比,研究了B16-F10和C-33A癌细胞系对纳米颗粒中ICG的细胞内摄取。进行了针对癌细胞的抗增殖研究,以证明ICG在纳米颗粒中的光动力学活性。通过尾静脉注射后,在小鼠中评估了ICG通过纳米颗粒和溶液递送时的生物分布。结果。获得了平均直径为350 nm和74%ICG截留的PLGA纳米颗粒。纳米粒子的形状接近球形,ζ电势为-16 mV。纳米粒子配方为ICG提供了整体稳定性,而降解半衰期为2.5--3.5天,而游离ICG溶液为10--20小时。 ICG通过纳米颗粒的细胞内摄取与时间和细胞外纳米颗粒浓度成正比。与游离ICG溶液相比,纳米颗粒制剂将ICG在细胞内的吸收提高了约100倍。纳米颗粒制剂在纳米摩尔ICG浓度和非常低的光剂量(通量:0.22 W / cm2和能量密度:1.1 J / cm2)下显示出显着的光动力效应。在体内,与游离ICG溶液相比,纳米颗粒制剂使ICG在各种器官中的血液循环时间和保留时间提高了2--5倍。结论。开发了用于ICG的PLGA纳米颗粒递送系统,证明了其具有增强ICG在肿瘤诊断和抗癌治疗中应用潜力的能力。

著录项

  • 作者

    Saxena, Vishal.;

  • 作者单位

    St. John's University (New York), School of Pharmacy.;

  • 授予单位 St. John's University (New York), School of Pharmacy.;
  • 学科 Psychology Social.; Chemistry Pharmaceutical.; Health Sciences Radiology.; Physics Optics.
  • 学位 Ph.D.
  • 年度 2005
  • 页码 166 p.
  • 总页数 166
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 社会心理、社会行为;药物化学;预防医学、卫生学;光学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号